Tag: Jane Jiang
Firms advise on GSK’s USD2.2bn RAPT buy, accesses China drug
British pharmaceutical giant GSK has entered an agreement to acquire US-based clinical-stage biopharmaceutical company RAPT Therapeutics for around USD2.2 billion
LATEST ON LAW.ASIA
Wealth in transition
An unprecedented transfer of private wealth is colliding with tighter regulation and rising complexity
MOST READ ON LAW.ASIA
Ship shape?
Leading maritime lawyers and in-house counsel share insights on what it means for carriers, cargo owners and insurers
